FibroBiologics' Chairman & CEO Pete O'Heeron Selected to Present at A4LI's H-SPAN Summit

O'Heeron to address longevity research and policy at prestigious Georgetown University event.

Published on Feb. 10, 2026

Got story updates? Submit your updates here. ›

FibroBiologics, a clinical-stage biotechnology company focused on developing treatments for chronic diseases using fibroblast cells and materials, announced that its Chairman and CEO Pete O'Heeron has been invited to serve as a main stage speaker at the upcoming A4LI's H-SPAN Summit at Georgetown University. The summit, hosted by the Alliance for Longevity Initiatives (A4LI), is a premier event bringing together leaders, innovators, policymakers, and advocates to advance legislative and scientific initiatives aimed at promoting healthier human lifespans.

Why it matters

FibroBiologics' work in cellular therapeutics and regenerative medicine aligns with the summit's focus on advancing longevity science and translating research into real-world clinical impact. O'Heeron's participation underscores the company's commitment to addressing chronic diseases and extending healthy human lifespan.

The details

At the summit, O'Heeron will address an expert audience of researchers, biotech executives, and policy leaders on the next frontier of longevity science, including breakthroughs in cellular therapeutics. The three-day event will feature cutting-edge longevity research, frameworks for innovation policy, and advocacy with members of Congress to elevate national healthspan priorities.

  • The H-SPAN Summit will take place June 29–July 1, 2026.
  • FibroBiologics announced O'Heeron's selection as a main stage speaker on February 10, 2026.

The players

FibroBiologics, Inc.

A clinical-stage biotechnology company with 270+ patents issued and pending, focused on developing therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials.

Pete O'Heeron

The Chairman and CEO of FibroBiologics, who has been invited to serve as a main stage speaker at the upcoming A4LI's H-SPAN Summit.

Alliance for Longevity Initiatives (A4LI)

A 501(c)(4) organization advancing legislation and policies that aim to increase healthy human lifespan and accelerate equitable access to next-generation therapies.

Dylan Livingston

The Founder and CEO of the Alliance For Longevity Initiatives.

Georgetown University

The host of the A4LI's H-SPAN Summit, which will be held on the Georgetown University Capitol Campus.

Got photos? Submit your photos here. ›

What they’re saying

“We are proud to have Pete represent FibroBiologics on the H-SPAN stage. Thymic regenerative biology is a potentially transformative area of research for extending healthy human lifespan, and Pete is a trailblazer in this space. FibroBiologics' commitment to addressing chronic diseases aligns directly with the goals of the summit and A4LI's mission of accelerating innovation that extends human healthspan.”

— Dylan Livingston, Founder/CEO of Alliance For Longevity Initiatives (FibroBiologics press release)

“I'm honored to be selected as one of the main stage speakers for the H-SPAN Summit and to contribute to this important national dialogue. FibroBiologics is committed to advancing therapies that prevent and treat chronic disease along with extending human life, and summits like this are essential for aligning scientific innovation with policy action.”

— Pete O'Heeron, Chairman and CEO of FibroBiologics (FibroBiologics press release)

What’s next

The H-SPAN Summit will take place June 29–July 1, 2026, culminating in a Congressional Briefing and Hill Day on Capitol Hill.

The takeaway

FibroBiologics' participation in the prestigious H-SPAN Summit underscores the company's leadership in the longevity science field and its commitment to advancing therapies that address chronic diseases and extend healthy human lifespan through innovative cellular therapeutics.